Modular Medical, Inc. (MODD) stock
MODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$1.82+0.02 (+1.11%)
Close on Nov 18, 2026Market cap $14.83MP/E –Yield –
Modular Medical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Modular Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$28.04M. For fiscal 2026 it was -$27.69M. The highest annual figure on record is $0 in fiscal 2011.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$27.69M | – |
| FY2025 | Mar 31, 2025 | -$18.21M | – |
| FY2024 | Mar 31, 2024 | -$15.65M | – |
| FY2023 | Mar 31, 2023 | -$12.65M | – |
| FY2022 | Mar 31, 2022 | -$10.31M | – |
| FY2021 | Mar 31, 2021 | -$6.02M | – |
| FY2020 | Mar 31, 2020 | -$4.36M | – |
| FY2019 | Mar 31, 2019 | -$1.89M | – |
| FY2014 | Jun 30, 2014 | $0 | – |
| FY2013 | Jun 30, 2013 | $0 | – |
| FY2012 | Jun 30, 2012 | $0 | – |
| FY2011 | Jun 30, 2011 | $0 | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$6.66M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$6.82M | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$8.38M | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$6.18M | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$6.31M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$5.26M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$4.64M | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$3.93M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$4.39M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$3.99M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$4.46M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$3.62M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$3.58M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$3.89M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$3.15M | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$2.86M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$2.75M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$3.16M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$2.34M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$2.58M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$2.22M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$1.34M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$1.56M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$1.60M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$1.52M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$1.52M | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$1.06M | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$930.92K | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$847.14K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$723.06K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$553.15K | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$366.47K | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$242.39K | – |
See a number that looks wrong?